Women are more likely to have asthma, have more severe symptoms, and are more likely to die from their asthma.
Many women experience a significant worsening of symptoms around menstruation and are at risk of potentially fatal asthma attacks every month. But there is very little research to understand why.
So, we’ve brought world leading scientists, funders and pharmaceutical companies together to transform outcomes for women with asthma. Read the report
We’re calling for funders to:
- Immediate large-scale public funding call: to investigate the influence of sex and gender differences on adult asthma.
- Fund a global team science approach: develop a new, international funding call for a public-private consortium
- Look for sex inequality: mandate all future studies to analyse their datasets by sex to identify differences
We’re enabling and encouraging researchers, innovators, and industry:
- Map the way forward: publish a scientific roadmap for investigating sex hormones and asthma in women, identifying key research questions with clear diagnostic and therapeutic goals.
- Create cross-disciplinary collaborations: drive the development of new collaborations across disciplines, particularly endocrinology.
- Engage innovators: leverage data collected by digital health companies who are supporting women through their menstrual cycles.